IL6 and COVID-19: These insights contribute to a more profound understanding of the inflammatory cascade in COVID-19 and reinforce the potential of NLR and IL-6 as biomarkers for guiding therapeutic strategies, particularly in the high-stakes decision-making process around intubation and ventilatory support.